Praxis Precision Medicines (PRAX) Cash & Equivalents Growth (3y) (2022 - 2026)

Praxis Precision Medicines (PRAX) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 13.29%
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 10.63%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -16.07%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -8.88%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Praxis Precision Medicines 9.37 Bn 8.58 Bn - 87.90%

Historic Data

Download Data
DateValue
Mar 31, 2026 87.90%
Dec 31, 2025 79.66%
Sep 30, 2025 33.79%
Jun 30, 2025 41.10%
Mar 31, 2025 28.60%
Dec 31, 2024 15.80%
Sep 30, 2024 0.59%
Jun 30, 2024 -6.20%
Mar 31, 2024 5.04%
Dec 31, 2023 -35.04%
Sep 30, 2023 -4.14%
Jun 30, 2023 84.64%
Mar 31, 2023 134.79%
Dec 31, 2022 11.20%
Sep 30, 2022 143.59%